This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Encompass Health's (EHC) Q4 Earnings Miss Mark, Increase Y/Y
by Zacks Equity Research
Encompass Health's (EHC) Q4 results reflect escalating costs, partly offset by higher revenues, courtesy of its Inpatient Rehabilitation segment.
Cigna's (CI) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Cigna's (CI) fourth-quarter earnings results likely to reflect higher revenues and solid segmental contributions.
HCA Healthcare's (HCA) Q4 Earnings Miss Mark, Improve Y/Y
by Zacks Equity Research
HCA Healthcare's (HCA) Q4 results reflect higher expenses, partly offset by better revenues owing to improved patient volumes.
HCA Healthcare (HCA) Q4 Earnings and Revenues Miss Estimates
by Zacks Equity Research
HCA (HCA) delivered earnings and revenue surprises of -2.86% and 2.25%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Why HCA Healthcare (HCA) Might Surprise This Earnings Season
by Zacks Equity Research
HCA Healthcare (HCA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Is a Beat in Store for HCA Healthcare's (HCA) Q4 Earnings?
by Zacks Equity Research
HCA Healthcare's (HCA) fourth-quarter earnings are likely to have gained from rising admissions and higher revenues.
Anthem (ANTM) Gears Up for Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Anthem's (ANTM) fourth-quarter results are likely to reflect gains from increased premiums and strong membership growth across its Medicare and Medicaid businesses, partly offset by rising expenses.
HCA Healthcare (HCA) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
HCA (HCA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Top Stock Reports for NVIDIA, Chevron & Accenture
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Chevron Corporation (CVX), and Accenture plc (ACN).
UnitedHealth (UNH) Q4 Earnings Beat Estimates, Improve Y/Y
by Zacks Equity Research
UnitedHealth's (UNH) Q4 results reflect higher revenues, driven by segmental contributions, partly offset by steep expenses.
Encompass Health (EHC) Unveils Hospital Plan in Osceola County
by Zacks Equity Research
Encompass Health (EHC) announces plans to construct a rehabilitation facility in Osceola County, FL, which aims to facilitate improved rehabilitation services throughout the region.
Earnings Growth & Price Strength Make HCA Healthcare (HCA) a Stock to Watch
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
What's in Store for UnitedHealth Group's (UNH) Q4 Earnings?
by Zacks Equity Research
UnitedHealth's (UNH) Q4 results are likely to reflect a rise in earnings and revenues on the back of solid segmental contributions.
Why HCA (HCA) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
HCA (HCA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Ensign Group (ENSG) Buys Nursing Facility to Expand in Arizona
by Zacks Equity Research
Ensign Group (ENSG) acquires operations of Estrella Health and Rehabilitation Center in Arizona to grow its portfolio and boost U.S. presence.
HCA Healthcare (HCA) Arm Opens Hospital to Aid Florida Presence
by Zacks Equity Research
HCA Healthcare's (HCA) West Florida Division opens Hospital for Endocrine Surgery to boost portfolio and establish further dominance in the state.
Encompass Health (EHC) Forms JV, Boosts Presence in Idaho
by Zacks Equity Research
Encompass Health (EHC) forms a JV with Saint Alphonsus for offering better home health and hospice services across Idaho.
HCA Healthcare (HCA) Buys MD Now, Boosts Florida Presence
by Zacks Equity Research
The acquisition of MD Now adds 59 Florida urgent care clinics to HCA Healthcare's (HCA) portfolio.
Acadia (ACHC) Buys CenterPointe Assets, Boosts Missouri Footprint
by Zacks Equity Research
Acadia Healthcare (ACHC) acquires the assets of Missouri-based CenterPointe Behavioral Health System in order to offer high-quality behavioral healthcare services across the state.
Is First Trust Health Care AlphaDEX ETF (FXH) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FXH
The Zacks Analyst Blog Highlights: Community Health Systems, Mednax, HCA Healthcare and Tenet Healthcare
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Community Health Systems, Mednax, HCA Healthcare and Tenet Healthcare
Magellan (MGLN) Unit to Unveil Wellbeing Program for Members
by Zacks Equity Research
Magellan's (MGLN) unit - Magellan Healthcare - partners with NeuroFlow to launch a wellbeing solution for empowering MGLN's members in independently managing their health issues.
3 Hospital Stocks That Crushed S&P 500 YTD, Set to Rise Further
by Srijita Guha
High patient volumes, mergers and buyouts, and demand for virtual health services are likely to help hospital companies like THC, HCA and CYH.
HCA Healthcare (HCA) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, HCA Healthcare (HCA) closed at $256.76, marking a +1.18% move from the previous day.
HCA Healthcare (HCA) Up 53.3% in a Year: More Room to Run?
by Zacks Equity Research
HCA Healthcare's (HCA) strategic measures and strong patient volumes will likely lead to better revenues, thus perking up its share price.